| 1 | Ulcerative colitis. Ungaro R · 2017 · Lancet | | 2,867 |
| 2 | British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Lamb CA · 2019 · Gut | | 1,824 |
| 3 | IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Grivennikov S · 2009 · Cancer Cell | | 1,815 |
| 4 | Ulcerative colitis. Ordás I · 2012 · Lancet | | 1,735 |
| 5 | Epidemiology and natural history of inflammatory bowel diseases. Cosnes J · 2011 · Gastroenterology | | 1,653 |
| 6 | Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Riddell RH · 1983 · Hum Pathol | | 1,590 |
| 7 | Inflammatory bowel disease: clinical aspects and established and evolving therapies. Baumgart DC · 2007 · Lancet | | 1,440 |
| 8 | Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. Magro F · 2017 · J Crohns Colitis | | 1,440 |
| 9 | Ulcerative colitis and colorectal cancer. A population-based study. Ekbom A · 1990 · N Engl J Med | | 1,439 |
| 10 | Cyclosporine in severe ulcerative colitis refractory to steroid therapy. Lichtiger S · 1994 · N Engl J Med | | 1,433 |
| 11 | Ulcerative colitis. Kobayashi T · 2020 · Nat Rev Dis Primers | | 1,324 |
| 12 | Ulcerative colitis. Le Berre C · 2023 · Lancet | | 1,176 |
| 13 | Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Anderson CA · 2011 · Nat Genet | | 1,078 |
| 14 | Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gionchetti P · 2000 · Gastroenterology | | 1,021 |
| 15 | Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Itzkowitz SH · 2004 · Am J Physiol Gastrointest Liver Physiol | | 1,019 |
| 16 | Ileal pouch-anal anastomoses complications and function in 1005 patients. Fazio VW · 1995 · Ann Surg | | 958 |
| 17 | Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Frøslie KF · 2007 · Gastroenterology | | 936 |
| 18 | Intestinal inflammation and cancer. Ullman TA · 2011 · Gastroenterology | | 912 |
| 19 | Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Järnerot G · 2005 · Gastroenterology | | 831 |
| 20 | Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Colombel JF · 2011 · Gastroenterology | | 766 |
| 21 | Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. Popivanova BK · 2008 · J Clin Invest | | 755 |
| 22 | Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gionchetti P · 2003 · Gastroenterology | | 748 |
| 23 | Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. Dignass A · 2012 · J Crohns Colitis | | 735 |
| 24 | Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Jess T · 2012 · Clin Gastroenterol Hepatol | | 722 |
| 25 | Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Zhang M · 2016 · Biomaterials | | 687 |
| 26 | Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation. Sinha SR · 2020 · Cell Host Microbe | | 661 |
| 27 | Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Kiesslich R · 2003 · Gastroenterology | | 650 |
| 28 | Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management. Shah SC · 2022 · Gastroenterology | | 643 |
| 29 | Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gupta RB · 2007 · Gastroenterology | | 624 |
| 30 | European evidence based consensus for endoscopy in inflammatory bowel disease. Annese V · 2013 · J Crohns Colitis | | 612 |
| 31 | Predicting outcome in severe ulcerative colitis. Travis SP · 1996 · Gut | | 601 |
| 32 | Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Solberg IC · 2009 · Scand J Gastroenterol | | 594 |
| 33 | Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Sandborn WJ · 1994 · Mayo Clin Proc | | 584 |
| 34 | AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis. Feuerstein JD · 2020 · Gastroenterology | | 557 |
| 35 | Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. Becker JM · 1996 · J Am Coll Surg | | 545 |
| 36 | Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Fazio VW · 2013 · Ann Surg | | 535 |
| 37 | Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Fukata M · 2007 · Gastroenterology | | 527 |
| 38 | Course of ulcerative colitis: analysis of changes in disease activity over years. Langholz E · 1994 · Gastroenterology | | 526 |
| 39 | Ulcerative Colitis in Adults: A Review. Gros B · 2023 · JAMA | | 515 |
| 40 | Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Turner D · 2007 · Clin Gastroenterol Hepatol | | 506 |
| 41 | Intraluminal pH of the human gastrointestinal tract. Fallingborg J · 1999 · Dan Med Bull | | 500 |
| 42 | Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Kelly CR · 2014 · Am J Gastroenterol | | 498 |
| 43 | Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Laharie D · 2012 · Lancet | | 492 |
| 44 | Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Liang J · 2013 · Cancer Cell | | 489 |
| 45 | Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Rutter MD · 2006 · Gastroenterology | | 485 |
| 46 | A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. Saxon A · 1990 · J Allergy Clin Immunol | | 479 |
| 47 | Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis. Nowarski R · 2015 · Cell | | 471 |
| 48 | Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Schmitz H · 1999 · Gastroenterology | | 467 |
| 49 | J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Meagher AP · 1998 · Br J Surg | | 461 |
| 50 | Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis. Seow CH · 2010 · Gut | | 453 |
| 51 | Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Bernstein CN · 1994 · Lancet | | 452 |
| 52 | Impact of Clostridium difficile on inflammatory bowel disease. Issa M · 2007 · Clin Gastroenterol Hepatol | | 449 |
| 53 | Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Lutgens MW · 2013 · Inflamm Bowel Dis | | 434 |
| 54 | A comprehensive review and update on ulcerative colitis. Gajendran M · 2019 · Dis Mon | | 429 |
| 55 | Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Itzkowitz SH · 2005 · Inflamm Bowel Dis | | 423 |
| 56 | Evidence-based clinical practice guidelines for inflammatory bowel disease. Matsuoka K · 2018 · J Gastroenterol | | 396 |
| 57 | Ileal pouch-anal anastomosis for chronic ulcerative colitis. Long-term results. Pemberton JH · 1987 · Ann Surg | | 395 |
| 58 | Colorectal cancer risk and mortality in patients with ulcerative colitis. Langholz E · 1992 · Gastroenterology | | 394 |
| 59 | Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Ardizzone S · 2006 · Gut | | 391 |
| 60 | Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gillen CD · 1994 · Gut | | 389 |
| 61 | Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. Turner D · 2018 · J Pediatr Gastroenterol Nutr | | 382 |
| 62 | C-reactive protein as a marker for inflammatory bowel disease. Vermeire S · 2004 · Inflamm Bowel Dis | | 379 |
| 63 | A comprehensive review and update on Crohn's disease. Gajendran M · 2018 · Dis Mon | | 379 |
| 64 | Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Lennard-Jones JE · 1990 · Gut | | 377 |
| 65 | Greater risk of incisional hernia with morbidly obese than steroid-dependent patients and low recurrence with prefascial polypropylene mesh. Sugerman HJ · 1996 · Am J Surg | | 371 |
| 66 | Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Penna C · 1996 · Gut | | 371 |
| 67 | Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. Fumery M · 2018 · Clin Gastroenterol Hepatol | | 368 |
| 68 | Long-term functional outcome and quality of life after stapled restorative proctocolectomy. Fazio VW · 1999 · Ann Surg | | 364 |
| 69 | Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Connell WR · 1994 · Gastroenterology | | 364 |
| 70 | Intra-abdominal pressure, sagittal abdominal diameter and obesity comorbidity. Sugerman H · 1997 · J Intern Med | | 363 |
| 71 | Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Brentnall TA · 1994 · Gastroenterology | | 363 |
| 72 | Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Seril DN · 2003 · Carcinogenesis | | 356 |
| 73 | Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Sandborn WJ · 2009 · Gastroenterology | | 355 |
| 74 | Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Bryant RV · 2016 · Gut | | 354 |
| 75 | The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? D'Haens GR · 2011 · Am J Gastroenterol | | 354 |
| 76 | A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Ogata H · 2006 · Gut | | 352 |
| 77 | Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Sands BE · 2001 · Inflamm Bowel Dis | | 348 |
| 78 | The Burden of Inflammatory Bowel Disease in Europe in 2020. Zhao M · 2021 · J Crohns Colitis | | 343 |
| 79 | CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. Longman RS · 2014 · J Exp Med | | 334 |
| 80 | Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Van Assche G · 2003 · Gastroenterology | | 330 |
| 81 | Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. Uronis JM · 2009 · PLoS One | | 327 |
| 82 | Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Itzkowitz SH · 2004 · Gastroenterology | | 322 |
| 83 | Recent insights into the genetics of inflammatory bowel disease. Cho JH · 2011 · Gastroenterology | | 321 |
| 84 | The pattern and outcome of acute severe colitis. Dinesen LC · 2010 · J Crohns Colitis | | 321 |
| 85 | Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. D'Haens G · 2001 · Gastroenterology | | 319 |
| 86 | Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Sandborn WJ · 1994 · Gastroenterology | | 319 |
| 87 | Chronic ulcerative colitis and colorectal cancer. Rogler G · 2014 · Cancer Lett | | 318 |
| 88 | Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Triantafillidis JK · 2009 · Anticancer Res | | 316 |
| 89 | Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Jess T · 2007 · Inflamm Bowel Dis | | 314 |
| 90 | Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Rubin DC · 2012 · Front Immunol | | 312 |
| 91 | East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Burisch J · 2014 · Gut | | 311 |
| 92 | Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Lohmuller JL · 1990 · Ann Surg | | 307 |
| 93 | Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Farmer RG · 1993 · Dig Dis Sci | | 304 |
| 94 | Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis. Shah SC · 2016 · Clin Gastroenterol Hepatol | | 303 |
| 95 | An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Moskowitz RL · 1986 · Int J Colorectal Dis | | 300 |
| 96 | Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases. Piechota-Polanczyk A · 2014 · Naunyn Schmiedebergs Arch Pharmacol | | 297 |
| 97 | Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Hahnloser D · 2007 · Br J Surg | | 297 |
| 98 | Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lichtiger S · 1990 · Lancet | | 294 |
| 99 | Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Charpentier C · 2014 · Gut | | 293 |
| 100 | Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Duerr RH · 1991 · Gastroenterology | | 286 |